| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Edgar Antezana-Chavez, Tomás Francisco Cianciulli, Claudio León Hadid, Dario Di Toro, Leonardo Celano, María Cristina Saccheri, Karina Giselle Baez, Carlos Alfredo Lopez, Carlos David Labadet, Juan Alberto Gagliard. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy. The American journal of cardiology. 2022-07-09. PMID:35810008. |
value of electrocardiography to distinguish fabry disease from sarcomeric hypertrophic cardiomyopathy. |
2022-07-09 |
2023-08-14 |
Not clear |
| Edgar Antezana-Chavez, Tomás Francisco Cianciulli, Claudio León Hadid, Dario Di Toro, Leonardo Celano, María Cristina Saccheri, Karina Giselle Baez, Carlos Alfredo Lopez, Carlos David Labadet, Juan Alberto Gagliard. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy. The American journal of cardiology. 2022-07-09. PMID:35810008. |
fabry disease (fd) is a rare genetic disorder that leads to left ventricular hypertrophy (lvh), frequently misdiagnosed as hypertrophic cardiomyopathy (hcm). |
2022-07-09 |
2023-08-14 |
Not clear |
| John Tremblay, Samuel Kim, Edward Philbin, Kelly Beers, Andrea Lightle, Dmitri Belo. Late-onset Fabry disease: the cardiac sequela. BMJ case reports. vol 15. issue 6. 2022-06-09. PMID:35680278. |
we describe a patient with fabry disease (fd) who initially presented with atrial fibrillation without left ventricular hypertrophy (lvh) 14 years before being correctly diagnosed with fd. |
2022-06-09 |
2023-08-14 |
Not clear |
| Toru Kubo, Masashi Amano, Seiji Takashio, Takahiro Okumura, Saori Yamamoto, Takeru Nabeta, Masayoshi Oikawa, Satoshi Kurisu, Yuri Ochi, Kenta Sugiura, Yuichi Baba, Hajime Kuroiwa, Takayoshi Hirota, Naohito Yamasaki, Shunsuke Ishii, Kotaro Nochioka, Yasuchika Takeishi, Satoshi Yasuda, Kenichi Tsujita, Chisato Izumi, Hiroaki Kitaok. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients. Journal of cardiology. 2022-06-01. PMID:35643740. |
a retrospective investigation to establish new screening approach for the detection of patients at high risk of fabry disease in male left ventricular hypertrophy patients. |
2022-06-01 |
2023-08-13 |
Not clear |
| Toru Kubo, Masashi Amano, Seiji Takashio, Takahiro Okumura, Saori Yamamoto, Takeru Nabeta, Masayoshi Oikawa, Satoshi Kurisu, Yuri Ochi, Kenta Sugiura, Yuichi Baba, Hajime Kuroiwa, Takayoshi Hirota, Naohito Yamasaki, Shunsuke Ishii, Kotaro Nochioka, Yasuchika Takeishi, Satoshi Yasuda, Kenichi Tsujita, Chisato Izumi, Hiroaki Kitaok. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients. Journal of cardiology. 2022-06-01. PMID:35643740. |
the prevalence of fabry disease (fd) in male patients with left ventricular hypertrophy (lvh) is about 1%. |
2022-06-01 |
2023-08-13 |
Not clear |
| K Savostyanov, A Pushkov, I Zhanin, N Mazanova, S Trufanov, A Pakhomov, A Alexeeva, D Sladkov, A Asanov, A Fisenk. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology. Orphanet journal of rare diseases. vol 17. issue 1. 2022-05-16. PMID:35578305. |
the prevalence of fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a russian nationwide screening program using ngs technology. |
2022-05-16 |
2023-08-13 |
Not clear |
| K Savostyanov, A Pushkov, I Zhanin, N Mazanova, S Trufanov, A Pakhomov, A Alexeeva, D Sladkov, A Asanov, A Fisenk. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology. Orphanet journal of rare diseases. vol 17. issue 1. 2022-05-16. PMID:35578305. |
many of these studies are related to the estimation of fabry disease (fd) morbidity among patients from high-risk groups, including adult patients with hypertrophic cardiomyopathy (hcm) and left ventricular hypertrophy (lvh). |
2022-05-16 |
2023-08-13 |
Not clear |
| Begum Yetis Sayin, Ali Ot. Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiology and therapy. 2022-03-30. PMID:35353354. |
frequent causes of hypertrophy include etiologies due to pressure/volume overload, such as systemic hypertension, hypertrophic cardiomyopathy, or infiltrative cardiac processes such as amyloidosis, fabry disease, and sarcoidosis. |
2022-03-30 |
2023-08-13 |
Not clear |
| Begum Yetis Sayin, Ali Ot. Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiology and therapy. 2022-03-30. PMID:35353354. |
in this review we systematically summarize treatments for the different patterns of cardiac hypertrophy and their impacts on outcomes while informing clinicians on advances in the treatment of lvh due to fabry disease, cardiac amyloidosis, and hypertrophic cardiomyopathy. |
2022-03-30 |
2023-08-13 |
Not clear |
| Shaimaa A Fadl, Jonathan W Revels, Leila Rezai Gharai, Kate Hanneman, Franklin Dana, Elizabeth Kate Proffitt, John D Grizzar. Cardiac MRI of Hereditary Cardiomyopathy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-03-11. PMID:35275782. |
it clearly shows regions of asymmetric wall thickening that are typical of hypertrophic cardiomyopathy and allows it to be differentiated from other hereditary disorders such as fabry disease or transthyretin cardiac amyloidosis that produce concentric hypertrophy. |
2022-03-11 |
2023-08-13 |
Not clear |
| Shaimaa A Fadl, Jonathan W Revels, Leila Rezai Gharai, Kate Hanneman, Franklin Dana, Elizabeth Kate Proffitt, John D Grizzar. Cardiac MRI of Hereditary Cardiomyopathy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-03-11. PMID:35275782. |
late gadolinium enhancement provides a different tissue property and allows these latter two causes of concentric hypertrophy to be distinguished on the basis of their enhancement appearances (fabry disease shows midwall basal inferolateral enhancement, and amyloidosis shows global subendocardial enhancement). |
2022-03-11 |
2023-08-13 |
Not clear |
| Piotr Gościniak, Tomasz Baron, Sławomir Milczarek, Magdalena Kostkiewicz, Bogusław Machalińsk. Updates for the diagnosis and management of cardiac amyloidosis. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2022-02-23. PMID:35195962. |
the differential diagnosis of the causes of myocardial hypertrophy includes arterial hypertension, hypertrophic cardiomyopathy, aortic stenosis (as), athletic heart syndrome, fabry disease, and cardiac amyloidosis (ca). |
2022-02-23 |
2023-08-13 |
Not clear |
| Chung-Lin Lee, Shuan-Pei Lin, Dau-Ming Niu, Hsiang-Yu Li. Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis. International journal of medical sciences. vol 19. issue 1. 2022-01-03. PMID:34975306. |
fabry disease and the effectiveness of enzyme replacement therapy (ert) in left ventricular hypertrophy (lvh) improvement: a review and meta-analysis. |
2022-01-03 |
2023-08-13 |
Not clear |
| Marijana Tadic, Cesare Cuspidi, Sven Plein, Isidora Grozdic Milivojevic, Dao Wen Wang, Guido Grassi, Giuseppe Manci. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart failure reviews. vol 26. issue 6. 2021-12-01. PMID:32170529. |
furthermore, cmr can provide differentiation of lvh between hypertensive patients and cardiomyopathies (hypertrophic or fabry disease). |
2021-12-01 |
2023-08-13 |
Not clear |
| Kenji Onoue, Yoshihiko Sait. New treatment for myocardial diseases. Journal of cardiology. vol 77. issue 6. 2021-11-24. PMID:33250269. |
this article outlines the mechanism of action and clinical data of novel therapeutic agents specific for myocardial diseases such as dilated cardiomyopathy, hypertrophic cardiomyopathy, fabry disease, cardiac amyloidosis, and myocarditis. |
2021-11-24 |
2023-08-13 |
Not clear |
| Dominique P Germain, Sergey Moiseev, Fernando Suárez-Obando, Faisal Al Ismaili, Huda Al Khawaja, Gheona Altarescu, Fellype C Barreto, Farid Haddoum, Fatemeh Hadipour, Irina Maksimova, Mirelle Kramis, Sheela Nampoothiri, Khanh Ngoc Nguyen, Dau-Ming Niu, Juan Politei, Long-Sun Ro, Dung Vu Chi, Nan Chen, Sergey Kutse. The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease. Molecular genetics & genomic medicine. vol 9. issue 5. 2021-10-29. PMID:33835733. |
newborn screening and screening of at-risk populations, (e.g., patients with hypertrophic cardiomyopathy or undiagnosed nephropathies) can identify individuals with fabry disease. |
2021-10-29 |
2023-08-13 |
Not clear |
| Hidekazu Tanak. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. Journal of echocardiography. vol 19. issue 2. 2021-10-28. PMID:33460030. |
it is commonly detected in athletes, arterial hypertension, aortic stenosis, hypertrophic cardiomyopathy, cardiac amyloidosis, fabry disease, or friedreich's ataxia. |
2021-10-28 |
2023-08-13 |
Not clear |
| Hideki Fujii, Keiji Kono, Tetsushi Yamamoto, Tetsuari Onishi, Shunsuke Goto, Kentaro Nakai, Hiroya Kawai, Ken-Ichi Hirata, Masafumi Fukagawa, Shinichi Nish. Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease. Clinical kidney journal. vol 5. issue 6. 2021-10-21. PMID:24976967. |
effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with fabry disease. |
2021-10-21 |
2023-08-13 |
Not clear |
| Yan Xiao, Yang Sun, Tao Tian, Tian-Jie Wang, Ran-Xu Zhao, Ying Zhang, Lin-Ping Wang, Ya-Xin Liu, Chao-Xia Lu, Xian-Liang Zhou, Wei-Xian Yan. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy. The American journal of the medical sciences. vol 362. issue 3. 2021-10-18. PMID:34266644. |
prevalence and clinical characteristics of fabry disease in chinese patients with hypertrophic cardiomyopathy. |
2021-10-18 |
2023-08-13 |
Not clear |
| Yan Xiao, Yang Sun, Tao Tian, Tian-Jie Wang, Ran-Xu Zhao, Ying Zhang, Lin-Ping Wang, Ya-Xin Liu, Chao-Xia Lu, Xian-Liang Zhou, Wei-Xian Yan. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy. The American journal of the medical sciences. vol 362. issue 3. 2021-10-18. PMID:34266644. |
the prevalence of fabry disease (fd) in chinese patients with hypertrophic cardiomyopathy (hcm) is unclear. |
2021-10-18 |
2023-08-13 |
Not clear |